QUIDELORTHO CORP Shareholders' Equity
QUIDELORTHO CORP (QDEL) had Shareholders' Equity of $1.77 billion as of 2026-06-28, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-07
- 2026-06-28: Stockholders' Equity Attributable to Parent $1.77B.
- 2026-03-29: Stockholders' Equity Attributable to Parent $1.85B.
- 2025-12-28: Stockholders' Equity Attributable to Parent $1.92B.
- 2025-09-28: Stockholders' Equity Attributable to Parent $2.04B.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-28 | $1.77B 10-Q · filed 2026-08-07 |
| 2026-03-29 | $1.85B 10-Q · filed 2026-08-07 |
| 2025-12-28 | $1.92B 10-Q · filed 2026-08-07 |
| 2025-09-28 | $2.04B 10-Q · filed 2025-11-06 |
| 2025-06-29 | $2.79B 10-Q · filed 2026-08-07 |
| 2025-03-30 | $3.00B 10-Q · filed 2026-08-07 |
| 2024-12-29 | $2.98B 10-Q · filed 2026-08-07 |
| 2024-09-29 | $3.19B 10-Q · filed 2025-11-06 |
| 2024-06-30 | $3.17B 10-Q · filed 2025-11-06 |
| 2024-03-31 | $3.31B 10-Q · filed 2025-11-06 |
| 2023-12-31 | $5.01B 10-K · filed 2026-02-19 |
| 2023-10-01 | $4.97B 10-Q · filed 2024-11-08 |
| 2023-07-02 | $5.00B 10-Q · filed 2024-11-08 |
| 2023-04-02 | $5.00B 10-Q · filed 2024-11-08 |
| 2023-01-01 | $4.93B 10-K · filed 2026-02-19 |
| 2022-10-02 | $4.80B 10-Q · filed 2023-11-02 |
| 2022-07-03 | $4.92B 10-Q · filed 2023-11-02 |
| 2022-04-03 | $2.41B 10-Q · filed 2023-11-02 |
| 2022-01-02 | $1.93B 10-K · filed 2025-02-27 |
| 2021-10-03 | $1.63B 10-Q · filed 2022-11-04 |
| 2021-07-04 | $1.41B 10-Q · filed 2022-11-04 |
| 2021-04-04 | $1.49B 10-Q · filed 2022-11-04 |
| 2021-01-03 | $1.33B 10-K/A · filed 2024-08-01 |
| 2019-12-29 | $559.90M 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |